AC Immune SA Free Cash Flow (FCF) History (ACIU)
AC Immune SA reported −CHF70.2M in free cash flow for fiscal 2025, a decrease of CHF135.4M from the previous fiscal year, with a free cash flow margin of −1963.67%.
View full AC Immune SA company overviewAC Immune SA free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −CHF70.2M | −CHF135.4M | — | −1963.67% |
| 2024 | 2024-12-31 | CHF65.3M | CHF126.5M | — | +238.99% |
| 2023 | 2023-12-31 | −CHF61.2M | CHF13.6M | — | −413.55% |
| 2022 | 2022-12-31 | −CHF74.8M | −CHF6.5M | — | −1901.07% |
| 2021 | 2021-12-31 | −CHF68.3M | −CHF7.1M | — | — |
| 2020 | 2020-12-31 | −CHF61.2M | −CHF114.6M | — | −396.75% |
| 2019 | 2019-12-31 | CHF53.3M | CHF99.3M | — | +48.29% |
| 2018 | 2018-12-31 | −CHF45.9M | −CHF22.0M | — | −664.58% |
| 2017 | 2017-12-31 | −CHF23.9M | −CHF17.4M | — | −117.98% |
| 2016 | 2016-12-31 | −CHF6.5M | −CHF50.4M | — | −28.19% |
| 2015 | 2015-12-31 | CHF43.8M | — | — | +112.15% |
AC Immune SA quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2022 | 2022-09-30 | −CHF13.7M | — | — | −347.18% |
AC Immune SA free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −CHF61.2M to −CHF70.2M, a net decrease of CHF8.9M. AC Immune SA's latest reported quarter, Q3 2022, generated −CHF13.7M in free cash flow.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review AC Immune SA filings at SEC.gov ↗